UBS Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
|
|||||
|
2025
Q1 | $2.05M | Sell |
|
|||||
|
2024
Q4 | $2.38M | Buy |
|
|||||
|
2024
Q3 | $375K | Buy |
|
|||||
|
2024
Q2 | $205K | Sell |
|
|||||
|
2024
Q1 | $461K | Buy |
|
|||||
|
2023
Q4 | $649K | Buy |
|
|||||
|
2023
Q3 | $492K | Sell |
|
|||||
|
2023
Q2 | $687K | Buy |
|
|||||
|
2023
Q1 | $767K | Buy |
|
|||||
|
2022
Q4 | $475K | Buy |
|
|||||
|
2022
Q3 | $193K | Buy |
|
|||||
|
2022
Q2 | $205K | Sell |
|
|||||
|
2022
Q1 | $690K | Buy |
|
|||||
|
2021
Q4 | $1.39M | Sell |
|
|||||
|
2021
Q3 | $1.77M | Buy |
|
|||||
|
2021
Q2 | $625K | Sell |
|
|||||
|
2021
Q1 | $885K | Sell |
|
|||||
|
2020
Q4 | $1.36M | Sell |
|
|||||
|
2020
Q3 | $1.3M | Buy |
|
|||||
|
2020
Q2 | $1.11M | Sell |
|
|||||
|
2020
Q1 | $742K | Buy |
|
|||||
|
2019
Q4 | $297K | Sell |
|
|||||
|
2019
Q3 | $375K | Buy |
|